These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 15012991)
1. A highly toxic morphine-3-glucuronide derivative. Salvatella M; Arsequell G; Valencia G; Rodríguez RE Bioorg Med Chem Lett; 2004 Feb; 14(4):905-8. PubMed ID: 15012991 [TBL] [Abstract][Full Text] [Related]
2. Morphine sex-dependently induced place conditioning in adult Wistar rats. Karami M; Zarrindast MR Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832 [TBL] [Abstract][Full Text] [Related]
3. Effects of morphine metabolites on micturition in normal, unanaesthetized rats. Igawa Y; Westerling D; Mattiasson A; Andersson KE Br J Pharmacol; 1993 Sep; 110(1):257-62. PubMed ID: 8220887 [TBL] [Abstract][Full Text] [Related]
4. Effects of morphine glucuronides on the function of opioid receptors in human SK-N-SH cells. Baker L; Dye A; Ratka A Neurosci Lett; 2000 Mar; 281(1):1-4. PubMed ID: 10686401 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of morphine-6-glucuronide, an active metabolite of morphine, and morphine on locomotor activity in mice: involvement of the opioid receptor. Uchihashi Y; Kuribara H; Morita T; Kitani Y; Karasawa F; Sato T Pharmacol Toxicol; 1996 May; 78(5):322-6. PubMed ID: 8737968 [TBL] [Abstract][Full Text] [Related]
6. Morphine-6-glucuronide-induced locomotor stimulation in mice: role of opioid receptors. Grung M; Skurtveit S; Aasmundstad TA; Handal M; Alkana RL; Mørland J Pharmacol Toxicol; 1998 Jan; 82(1):3-10. PubMed ID: 9527644 [TBL] [Abstract][Full Text] [Related]
8. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems. Juni A; Klein G; Kest B Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of allodynia evoked by intrathecal morphine-3-glucuronide in mice. Komatsu T; Sakurada S; Katsuyama S; Sanai K; Sakurada T Int Rev Neurobiol; 2009; 85():207-19. PubMed ID: 19607972 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, conformation, and biological characterization of a sugar derivative of morphine that is a potent, long-lasting, and nontolerant antinociceptive. Arsequell G; Salvatella M; Valencia G; Fernández-Mayoralas A; Fontanella M; Venturi C; Jiménez-Barbero J; Marrón E; Rodríguez RE J Med Chem; 2009 May; 52(9):2656-66. PubMed ID: 19351163 [TBL] [Abstract][Full Text] [Related]
11. The importance of position six in the ring C of morphine in modulation of agonist/antagonist interaction with multiple opiate receptors. Fürst S; Friedmann T; Hosztafy S Acta Physiol Hung; 1990; 75 Suppl():115-6. PubMed ID: 2164747 [No Abstract] [Full Text] [Related]
12. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Rehni AK; Bhateja P; Singh TG; Singh N Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544 [TBL] [Abstract][Full Text] [Related]
13. Morphine-6-hemisuccinate as a narcotic analgesic. Gebhart GF; Spratt JL Life Sci; 1976 Apr; 18(8):829-35. PubMed ID: 944843 [No Abstract] [Full Text] [Related]
14. Synthesis of novel twin drug consisting of 8-oxaendoethanotetrahydromorphides with a 1,4-dioxane spacer and its pharmacological activities: mu, kappa, and putative epsilon opioid receptor antagonists. Fujii H; Watanabe A; Nemoto T; Narita M; Miyoshi K; Nakamura A; Suzuki T; Nagase H Bioorg Med Chem Lett; 2009 Jan; 19(2):438-41. PubMed ID: 19042127 [TBL] [Abstract][Full Text] [Related]
15. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system. Zarrindast MR; Sarahroodi S; Arzi A; Khodayar MJ; Taheri-Shalmani S; Rezayof A Behav Pharmacol; 2008 Oct; 19(7):716-23. PubMed ID: 18797248 [TBL] [Abstract][Full Text] [Related]
16. Capsaicin-induced avoidance behavior in the terrestrial Gastropoda Megalobulimus abbreviatus: evidence for TRPV-1 signaling and opioid modulation in response to chemical noxious stimuli. Kalil-Gaspar P; Marcuzzo S; Rigon P; Molina CG; Achaval M Comp Biochem Physiol A Mol Integr Physiol; 2007 Oct; 148(2):286-91. PubMed ID: 17553716 [TBL] [Abstract][Full Text] [Related]
17. Induction of c-Fos and zif268 in the nociceptive amygdala parallel abstinence hyperalgesia in rats briefly exposed to morphine. Hamlin AS; McNally GP; Osborne PB Neuropharmacology; 2007 Aug; 53(2):330-43. PubMed ID: 17631915 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites. Bartlett SE; Dodd PR; Smith MT Pharmacol Toxicol; 1994 Aug; 75(2):73-81. PubMed ID: 7971741 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice. Hiramatsu M; Hoshino T; Kanematsu K Behav Brain Res; 2005 May; 160(2):374-81. PubMed ID: 15863234 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of morphine analgesia by lithium: role of peripheral and central opioid receptors. Johnston IN; Westbrook RF Behav Brain Res; 2004 May; 151(1-2):151-8. PubMed ID: 15084430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]